Moreover, we have also found that mTORC1 is activated in podocytes of nondiabetic obese patients with CKD, so an evaluation of the involvement of the Tsc2 gene in nondiabetic obese patients with CKD might provide valuable clues for understanding the pathogenesis of obesity-related renal diseases. This evidence concerns the gene TSC2 and obesity disorder.